Five Days: Deal Making Heats Up as Does Food and Drug Scrutiny
115039
Deal makers powered ahead, even as one pending merger faced a regulatory hurdle. Makers of diabetes drugs agreed to use the most severe warning on labels, and broadcasters won a favorable federal court ruling regarding obscenities.
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
688197
For some investors, today may seem like a discount day for shares of the coffee purveyor.
140996
A day late and possibly several millions of dollars short. That's the scenario facing one drug manufacturer unless it can get a helping hand from Congress.
297660
With merger and acquisition fever hitting new highs, which deals will work out?
145921
With the stunning recall of a popular pain medication last week and the impact it had on patients, the stock market and its manufacturer, it may be worthwhile to review how drugs get to market and how safety data are gathered.
725391
More vendors report a number of regulatory agencies in different countries are looking into claims of price fixing.
708021
The pharma gives us its quest for bidders.
607304
Food and Drug Administration approvals kept medical device and drug company stocks in the spotlight with two device companies reporting product approvals Wednesday.
130395
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process. By Alexandra Marks | Staff writer of The Christian Science Monitor.
624845
Coca-Cola is expected to settle soon, perhaps as early as Tuesday, a five-year investigation by the European Union into allegations that the soft-drink company abused its market power to hurt rivals, according to a person familiar with the deal.
526791
Food producers and government sign an agreement to freeze prices for a range of basic foodstuffs.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
230593
Bargains or busts? Let's work together to find out.
560715
The regulatory approval was also a boost for the embattled drugs sector. It was feared that, following a series of safety crises, the US Food and Drug Administration would get tougher on new drugs.
547510
As merger fever hits new highs, which deals will work out?
199294
With M&A fever supposedly waning, which deals will work out?